Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences (TSE:WLLW)
:WLLW
RESEARCH TOOLSreports
Total Valuation
Willow Biosciences Inc has a market cap or net worth of C$4.42M. The enterprise value is C$3.88M.
Market CapC$4.42M
Enterprise ValueC$3.88M
Share Statistics
Willow Biosciences Inc has 147,196,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,196,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Willow Biosciences Inc’s return on equity (ROE) is 12.26 and return on invested capital (ROIC) is -408.86%.
Return on Equity (ROE)12.26
Return on Assets (ROA)-2.49
Return on Invested Capital (ROIC)-408.86%
Return on Capital Employed (ROCE)-12.08
Revenue Per Employee245.37K
Profits Per Employee-325.74K
Employee Count19
Asset Turnover1.87
Inventory Turnover24.75
Valuation Ratios
The current PE Ratio of Willow Biosciences Inc is -1.41. Willow Biosciences Inc’s PEG ratio is >-0.01.
PE Ratio-1.41
PS Ratio0.00
PB Ratio0.87
Price to Fair Value-17.32
Price to FCF-0.98
Price to Operating Cash Flow-1.03
PEG Ratio>-0.01
Income Statement
In the last 12 months, Willow Biosciences Inc had revenue of 4.66M and earned -6.19M in profits. Earnings per share was -0.05.
Revenue4.66M
Gross Profit3.28M
Operating Income-5.99M
Pretax Income-6.19M
Net Income-6.19M
EBITDA-4.54M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -3.72M and capital expenditures -20.00K, giving a free cash flow of -3.74M billion.
Operating Cash Flow-3.72M
Free Cash Flow-3.74M
Free Cash Flow per Share-0.03
Dividends & Yields
Willow Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.50
52-Week Price Change-70.00%
50-Day Moving Average0.03
200-Day Moving Average0.06
Relative Strength Index (RSI)47.97
Average Volume (3m)887.30K
Important Dates
Willow Biosciences Inc upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Willow Biosciences Inc as a current ratio of 0.33, with Debt / Equity ratio of 4.06%
Current Ratio0.33
Quick Ratio0.30
Debt to Market Cap0.08
Net Debt to EBITDA-0.36
Interest Coverage Ratio-22.78
Taxes
In the past 12 months, Willow Biosciences Inc has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Willow Biosciences Inc EV to EBITDA ratio is -2.29, with an EV/FCF ratio of -2.77.
EV to Sales2.23
EV to EBITDA-2.29
EV to Free Cash Flow-2.77
EV to Operating Cash Flow-2.79
Balance Sheet
Willow Biosciences Inc has C$353.00K in cash and marketable securities with C$1.97M in debt, giving a net cash position of C$1.62M billion.
Cash & Marketable SecuritiesC$353.00K
Total DebtC$1.97M
Net CashC$1.62M
Net Cash Per ShareC$0.01
Tangible Book Value Per Share>-C$0.01
Margins
Gross margin is -810.23%, with operating margin of -128.51%, and net profit margin of -132.75%.
Gross Margin-810.23%
Operating Margin-128.51%
Pretax Margin-132.69%
Net Profit Margin-132.75%
EBITDA Margin-97.32%
EBIT Margin-127.05%
Analyst Forecast
The average price target for Willow Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast571.23%
EPS Growth Forecast64.24%